Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

133
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
133
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synphilin-1 Is Essential for Cytoskeletal Integrity of Brain Ventricular Cilia and Mitochondrial Proteostasis.

International journal of molecular sciences·2026
Same author

Cannabigerol (CBG) Modulates Neutrophil Activity and Ameliorates Rheumatoid Arthritis Pathogenesis.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

CDK5 Inhibits Synphilin-1 Ubiquitination and Basal Mitophagy: Implications for Parkinson's Disease.

International journal of molecular sciences·2025
Same author

High CBD extract (CBD-X) modulates inflammation and immune cell activity in rheumatoid arthritis.

Frontiers in immunology·2025
Same author

Chronic cannabis use in breast cancer survivors: A questionnaire study of Israeli patients.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2025
Same author

High-CBD Extract (CBD-X) in Asthma Management: Reducing Th2-Driven Cytokine Secretion and Neutrophil/Eosinophil Activity.

Pharmaceuticals (Basel, Switzerland)·2024

Related Experiment Video

Updated: Jul 11, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

171

Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions.

Nicole Paland1, Haya Hamza1, Antonina Pechkovsky1

  • 1Medical Cannabis Research and Innovation Center, Rambam Health Care Campus, Haifa, Israel.

Rambam Maimonides Medical Journal
|November 2, 2023
PubMed
Summary

Cannabis shows potential for rheumatoid diseases due to anti-inflammatory and pain-relief properties. However, more clinical research is needed to establish its efficacy and safety for treating conditions like rheumatoid arthritis.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

139
Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

1.0K

Related Experiment Videos

Last Updated: Jul 11, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

171
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

139
Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

1.0K

Area of Science:

  • Rheumatology
  • Pharmacology

Background:

  • Rheumatoid diseases cause progressive joint inflammation, pain, and damage, reducing quality of life.
  • Current treatments for rheumatoid diseases have limited efficacy in disease modification and pain management.
  • Novel therapeutic strategies are urgently needed for rheumatoid diseases.

Purpose of the Study:

  • To review the potential of cannabinoids as a treatment for rheumatoid diseases.
  • To explore the anti-inflammatory and analgesic properties of cannabinoids in preclinical and clinical studies.
  • To assess the efficacy and safety of cannabis for rheumatoid disease treatment.

Main Methods:

  • Literature review of preclinical studies, clinical trials, and retrospective analyses.
  • Examination of data on cannabis and cannabinoid use for rheumatoid arthritis, osteoarthritis, and fibromyalgia.
  • Analysis of reported anti-inflammatory and analgesic effects and adverse events.

Main Results:

  • Preclinical studies suggest cannabinoids can reduce inflammation and pain in rheumatoid disease models.
  • Clinical data on cannabis for rheumatoid diseases are limited and show mixed results.
  • Adverse effects of cannabis use require careful consideration.

Conclusions:

  • Cannabinoids demonstrate therapeutic potential for rheumatoid diseases, warranting further investigation.
  • High-quality clinical trials are necessary to confirm the efficacy and safety of cannabis-based treatments.
  • Evidence is insufficient to establish clinical guidelines for using cannabis in rheumatoid disease management.